Product Details:
| Strength | 4 mg |
| Brand | zolasta |
| Manufacturer | intas |
| Pharmacopoeia Standard | IP |
| Packaging Type | Box |
| Storage Temperature | Below 30 degree c |
| Shelf Life | 36 months |
| Volume | 5 ml |
| Composition | Zoledronic Acid |
Zolasta 4 mg Injection (containing Zoledronic Acid) is a bisphosphonate used to strengthen bones, treat high calcium levels caused by cancer, and manage osteoporosis (including postmenopausal and steroid-induced). It reduces fracture risk, treats Paget’s disease, and treats bone complications in cancer patients.